Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05023980
Title A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-313)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Loxo Oncology, Inc.
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

LOXO-305

Bendamustine + Rituximab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | AUT


No variant requirements are available.